Dramatic Response to Ustekinumab Treatment in a Patient with Ankylosing Spondylitis and Crohn’s Disease and Anti-tumor Necrosis Factor-alpha Drug Induced Psoriasis

Journal Title: Turkish Journal of Osteoporosis - Year 2020, Vol 26, Issue 3

Abstract

Treatment with anti-tumour necrosis factor-alpha (anti-TNF-α) drugs provides significant improvements in many chronic inflammatory diseases with common pathogenesis, including Crohn’s disease, ankylosing spondylitis and psoriasis. However, during these treatments, paradoxically, cutaneous side effects such as psoriasis can be seen. Although its pathophysiology is well understood, it is thought that TNF-α blockade triggers locally excessive interferon-α production in predisposed subjects and causes psoriatic lesions. In this case report, we present a 50-year-old female patient with ankylosing spondylitis and Crohn’s disease who used adalimumab and then infliximab and developed psoriasiform lesions due to these drugs. Anti-TNF-α treatment was discontinued, and ustekinumab was started. Psoriasiform rashes improved; disease activity of ankylosing spondylitis and Crohn’s disease was suppressed. Ustekinumab may be a good option to manage ankylosing spondylitis and patients with Crohn’s disease who develop psoriasiform rashes due to anti-TNF-α drugs.

Authors and Affiliations

Sevilay Kılıç, Hatice Reşorlu, Alper Ekinci, Ayşe Selcen Bulut Keskin

Keywords

Related Articles

Role of Sesamoid Bone in the Etiology of Trigger Finger in Hand

Ultrasonography is the most important development that has been used in recent years during the diagnosis and treatment of musculoskeletal disorders. In this case report, the diagnosis process will be discussed due to ul...

Role of FRAX in the Evaluation of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease

Objective: The incidence of osteoporosis increased in patients with chronic obstructive pulmonary disease (COPD), and fractures due to osteoporosis are a significant cause of morbidity. Thus, risk assessment and taking n...

Evaluation of Bone Mineral Density in Treatment-naive Patients with Human Immundeficiency Virus Infection

Objective: Human Immundeficiency virus (HIV) infection is a risk factor for low bone mineral density (BMD). International HIV/AIDS guidelines do not recommend BMD screening for every patient. In this study, we aimed to c...

Is There Any Relationship Between Serum Endocan Levels and Carotid Intima-media Thickness in Patients with Fibromyalgia?

Objective: Although the pathophysiology of Fibromyalgia syndrome (FMS) has not yet been completely elucidated, it has been suggested that inflammation and endothelial dysfunction occur in patients with FMS. In recent yea...

Examination of the Etiologic Causes in Patients Presenting with Elevated Parathormone

Objective: Parathyroid hormone (PTH) levels are elevated in the blood due to various reasons and named as primary or secondary hyperparathyroidism. There is no any study that investigated the etiology of elevated PTH. M...

Download PDF file
  • EP ID EP691613
  • DOI 10.4274/tod.galenos.2020.71677
  • Views 93
  • Downloads 0

How To Cite

Sevilay Kılıç, Hatice Reşorlu, Alper Ekinci, Ayşe Selcen Bulut Keskin (2020). Dramatic Response to Ustekinumab Treatment in a Patient with Ankylosing Spondylitis and Crohn’s Disease and Anti-tumor Necrosis Factor-alpha Drug Induced Psoriasis. Turkish Journal of Osteoporosis, 26(3), -. https://europub.co.uk/articles/-A-691613